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Effect of zinc supplementation started during diarrhoea
on morbidity and mortality in Bangladeshi children:
community randomised trial
Abdullah H Baqui, Robert E Black, Shams El Arifeen, Mohammad Yunus, Joysnamoy Chakraborty,
Saifuddin Ahmed, J Patrick Vaughan
Abstract
Objective To evaluate the effect on morbidity and
mortality of providing daily zinc for 14 days to
children with diarrhoea.
Design Cluster randomised comparison.
Setting Matlab field site of International Center for
Diarrhoeal Disease Research, Bangladesh.
Participants 8070 children aged 3›59 months
contributed 11 881 child years of observation during
a two year period.
Intervention Children with diarrhoea in the
intervention clusters were treated with zinc (20 mg
per day for 14 days); all children with diarrhoea were
treated with oral rehydration therapy.
Main outcome measures Duration of episode of
diarrhoea, incidence of diarrhoea and acute lower
respiratory infections, admission to hospital for
diarrhoea or acute lower respiratory infections, and
child mortality.
Results About 40% (399/1007) of diarrhoeal
episodes were treated with zinc in the first four
months of the trial; the rate rose to 67% (350/526) in
month 5 and to > 80% (364/434) in month 7 and was
sustained at that level. Children from the intervention
cluster received zinc for about seven days on average
during each episode of diarrhoea. They had a shorter
duration (hazard ratio 0.76, 95% confidence interval
0.65 to 0.90) and lower incidence of diarrhoea (rate
ratio 0.85, 0.76 to 0.96) than children in the
comparison group. Incidence of acute lower
respiratory infection was reduced in the intervention
group but not in the comparison group. Admission to
hospital of children with diarrhoea was lower in the
intervention group than in the comparison group
(0.76, 0.59 to 0.98). Admission for acute lower
respiratory infection was lower in the intervention
group, but this was not statistically significant (0.81,
0.53 to 1.23). The rate of non›injury deaths in the
intervention clusters was considerably lower (0.49,
0.25 to 0.94).
Conclusions The lower rates of child morbidity and
mortality with zinc treatment represent substantial
benefits from a simple and inexpensive intervention
that can be incorporated in existing efforts to control
diarrhoeal disease.
Introduction
Zinc deficiency is highly prevalent in children in devel›
oping countries.1 Inadequacy of dietary zinc intake is
exacerbated by the net loss of zinc during diarrhoea.2
Zinc supplements given during diarrhoea reduce the
duration and severity of treated episodes3 and, if given
for 14 days during and after diarrhoea, can reduce the
incidence of diarrhoea and acute lower respiratory
infection in the subsequent two to three months.4 Pro›
vision of zinc during diarrhoea may thus be a feasible
strategy for both treatment of diarrhoea and
prevention of subsequent morbidity and mortality. The
therapeutic trials of zinc supplementation conducted
to date have been small and conducted in clinical
settings. We aimed to evaluate the impact on morbidity
and mortality of zinc treatment during diarrhoea in a
realistic large scale public health programme.
The study was based on the premises that the
dietary intake of zinc of most Bangladeshi children is
marginal, that many children become deficient during
episodes of diarrhoea, and that treatment of diarrhoea
with zinc will help to maintain an adequate zinc
balance and tissue function. We hypothesised that zinc
supplements given as treatment for two weeks in addi›
tion to oral rehydration treatment for all episodes of
diarrhoea in preschool children in Bangladesh would
reduce the duration of the treated episodes, the
incidence of diarrhoea and acute lower respiratory
infection, the number of admissions to hospital related
to diarrhoea or acute lower respiratory infections, and
mortality.
Methods
Study design and population
We conducted this community based, prospective, ran›
domised controlled trial in the Matlab field area of the
International Center for Diarrhoeal Disease Research,
Bangladesh (ICDDR,B): Centre for Health and
Population Research in Bangladesh. Matlab is a rural
subdistrict of Bangladesh where diarrhoea related
research has been conducted since 1963. A health and
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demographic surveillance system established in 1966
now operates in 144 villages with 210 000 people. This
surveillance system gathers vital event information on
births, deaths, and migrations on a regular basis
through home visits. In 1998 infant mortality in the
Matlab area was 60.6 per 1000 live births, and mortality
in children aged 1›4 years was 5.2 per 1000 children.
Diarrhoea accounted for about 12% of infant deaths
and about a third of all deaths in children aged 1›4
years.5
Since the inception of research in the Matlab area
patients with severe diarrhoea have been cared for in a
treatment centre at Matlab township, and patients with
severe acute lower respiratory infection have also been
treated there since 1980. Oral rehydration treatment
and referral for patients with diarrhoea are provided in
the villages by community health workers and by Bari
mothers—community volunteers who distribute oral
rehydration solution packets and provide advice to
patients with diarrhoea. The community health
workers also provide treatment and referral services
for acute lower respiratory infection. On average, there
is one community health worker for every 2000 people
and one Bari mother for every 50 people.
We selected for the study 30 service areas (clusters)
of community health workers around Matlab treat›
ment centre, each with about 200 children aged 3›47
months. We calculated sample size on the basis of a
method by Donner et al,6 with 80% power, 95% confi›
dence level, and a design effect of 3 to detect assumed
differences between the intervention and comparison
groups for the five primary outcomes—duration of
diarrhoea, incidence of diarrhoea and acute lower res›
piratory infection, and admission to hospital for
diarrhoea or acute lower respiratory infection. Our
final sample size, 11 772 child years of observation, was
the highest sample size needed to detect a 33% reduc›
tion in annual hospital admissions for acute lower res›
piratory infection from a baseline rate of 6 per 100
child years. We expected two years’ follow up of
children aged 3›59 months in the areas of 30 commu›
nity health workers to provide the required number of
child years of observation. Accordingly, we selected 30
community health worker service areas. Because data
for the entire two year period was not necessary for
assessment of the effects on duration of diarrhoeal epi›
sodes and on incidence of diarrhoea and acute lower
respiratory infection, we collected data for these
outcomes from samples of episodes and samples of
time periods.
We observed considerable variation in baseline
rates of admission to hospital for diarrhoea between
clusters. To minimise baseline differences in rates of
admission for diarrhoea between intervention and
comparison groups, we calculated the baseline rates by
study cluster for 1996›7. We assigned clusters to three
strata defined by baseline admission rates and
randomly selected clusters within each stratum for
intervention or comparison.
We initially enrolled children aged 3›47 months
who were permanent residents of the study cluster
areas. We also included all babies as they became 3
months old and all babies in the age range of 3›59
months moving into the area during the period of the
study, November 1998 to October 2000. Children with
a mid›upper arm circumference of < 110 mm were
excluded and referred to the Matlab treatment centre
for care. When study children became 60 months old
they were excluded.
The ethical review committees of ICDDR,B and the
Johns Hopkins School of Public Health approved the
study procedures. Because this was a community based
treatment trial, we obtained consent from the villages
through meetings that explained the purpose of the
study and potential risks and benefits of the new treat›
ment. We obtained verbal informed consent for data
collection from parents of intervention and compari›
son group children.
Intervention
The community health workers and Bari mothers in
the intervention clusters taught the mothers how to
use the zinc syrup. As soon as diarrhoea was reported,
study children in the intervention villages were to
receive 20 mg of elemental zinc as acetate each day for
14 days, regardless of the duration of the episode, in a
once daily dose of 5 ml. ACME Laboratories (Dhaka,
Bangladesh) prepared the syrup, and the biochemistry
laboratory of ICDDR,B independently confirmed its
zinc content. The children in the intervention and
comparison clusters received oral rehydration solu›
tion, and their mothers received advice on feeding
during diarrhoea and on referral to the Matlab
treatment centre, if needed.
Outcome definitions and follow up
Data collectors (n=12) who were not involved in the
implementation of the intervention made bi›monthly
home visits (six monthly in the second year of the
study) to collect data on morbidity from diarrhoea and
acute lower respiratory infection and adherence to zinc
treatment. The recall period was one week for
diarrhoea and two weeks for acute lower respiratory
infection. Diarrhoea was defined as three or more
loose, liquid, or watery stools or at least one loose stool
containing blood in a 24 hour period. If the stool con›
tained blood, the episode was classified as dysentery.
Acute lower respiratory infection was diagnosed if the
child had reported symptoms of cough, difficult
breathing and rapid breathing, or chest in›drawing. To
determine the duration of diarrhoeal episodes, each
data collector selected the first two active diarrhoeal
episodes (episodes that started within 48 hours of the
visit by the data collector and were continuing during
the visit) each week and followed them every third day
until they were resolved. Data on hospital admissions
related to diarrhoea or acute lower respiratory
infection (diagnosis made by physician) were collected
by surveillance in the Matlab treatment centre. Data on
deaths in study children were collected by the health
and demographic surveillance system of ICDDR,B,
which is independent of the study. Verbal autopsy was
conducted with the parents for all reported deaths by
using a standardised structured questionnaire to deter›
mine the causes of death, which were assigned with a
computer algorithm.7 To ensure data quality, the study
supervisors and investigators made spot checks, and a
5% sample of study children’s parents were
re›interviewed within two days of the original visit.
Data were entered using online programs with checks
of range and consistency.
We used data on follow up of selected diarrhoeal
episodes to determine the duration of episodes. We
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used recall periods for diarrhoea and acute lower
respiratory infection for which data were available as
denominators for calculating the incidence of diar›
rhoea and acute lower respiratory infection. We used
child years of passive surveillance calculated by
subtracting the entry date of the child in the study from
his or her exit date as the denominator to calculate
hospital admission and death rates.
We controlled for any significant baseline differ›
ences during data analysis. We used a Cox’s hazards
regression to assess the therapeutic effect of zinc on the
duration of diarrhoeal episodes,8 and we estimated the
effects of zinc treatment on other outcomes in two
ways. Firstly, using children as the unit of analysis, we
calculated rates, rate ratios, and 95% confidence
intervals, adjusting for covariates with random effect
Poisson regression.9 The model took into account the
duration of exposure for each child and the effect of
intracluster correlation. Secondly, we conducted a clus›
ter level analysis in which we used Student’s t test to
compare the mean rates in the intervention and com›
parison clusters adjusted for the distribution of
selected characteristics of children.6 10 The cluster level
t test provides t and P values and also provides
differences in mean rates and 95% confidence
intervals. (Because the confidence interval is around
the differences of mean rates, if it does not include zero
the groups are significantly different). We used Stata
software, version 7, to analyse the data.
Results
At the beginning of the study, the 15 intervention clus›
ters contained 2483 children aged 3›47 months and
the 15 comparison clusters contained 2502 children.
The trial profile (fig 1) shows the numbers of new chil›
dren added and children who moved out or who were
dropped from the study at 60 months of age. A total of
8070 children contributed 11 881 child years of obser›
vation. The age distribution of children in the interven›
tion cluster was similar to that in the comparison
cluster (table 1). Significantly more boys were in the
intervention clusters than the comparison clusters. The
distribution of children’s age and birth order, mothers’
education, homestead land size, and baseline diarrhoea
hospital admission rates were similar in the interven›
tion and comparison clusters (table 2).
About 40% (399/1007) of episodes were treated
with zinc in the first four months of the trial. Use of zinc
increased to about 67% (350/526) of episodes by
month 5 of the trial and to more than 80% (364/434)
by month 7, and was sustained at that level. On average,
intervention children received zinc for about seven
days during each episode of diarrhoea.
We followed 620 diarrhoeal episodes in the
intervention clusters and 632 episodes in the compari›
son clusters. The duration of diarrhoea in children
from the intervention clusters was 24% shorter than
that in the comparison group; the duration was signifi›
cantly shorter for both non›dysenteric diarrhoea and
dysentery (table 3).
Many children were part of the study for less than
two years. If the study children had contributed data for
all periods while they were in the study, data from
46 880 recall periods would have been generated. Data
were available for 41 788 (89%) periods. The incidence
of diarrhoea was 15% lower in the intervention clusters
than in the comparison clusters (table 4). The cluster
level analysis confirmed this finding (P < 0.01). A
slightly lower incidence of acute lower respiratory
infection in the intervention clusters was evident by the
end of the study, but the difference in rates between the
intervention and comparison groups over the full
study period was not significant. The intervention clus›
ters had a much higher incidence of acute lower respi›
ratory infection than the comparison clusters at the
start, and this incidence declined significantly over the
study period. No such trend was observed in the com›
parison clusters (fig 2). The trends in incidence of acute
lower respiratory infection in the intervention and
comparison clusters were significantly different when
tested using variance weighted least squares regression
(P < 0.001).
Children in the intervention clusters had a 24%
lower diarrhoea related admission rate than children in
the comparison clusters, which was a significant differ›
ence in the individual level analysis but not in the clus›
ter analysis. The admission rate for acute lower
respiratory infection was also lower (by 19%) in the
30 clusters randomly allocated after stratification
by baseline diarrhoea hospital admission rates
15 clusters in comparison
group (n=2502)
15 clusters in intervention
group (n=2483)
4096 children partly or
fully completed follow up,
resulting in 6015 child
years observed
3974 children partly or
fully completed follow up,
resulting in 5866 child
years observed
1594 children added
98 children moved out
528 children dropped
 from study as they
 became 60 months old
1491 children added
103 children moved out
529 children dropped
 from study as they
 became 60 months old
Fig 1 Trial profile
Table 1 Distribution of children by age and study group
Age (months)
Child years observed
Intervention Comparison Total
3›5 328.5 342.3 670.8
6›11 690.6 707.9 1398.5
12›23 1383.4 1409.3 2792.7
24›35 1322.8 1304.6 2627.4
36+ 2140.6 2250.6 4391.2
Total 5865.9 6014.7 11 880.6
Table 2 Selected characteristics of children at entry to study. Values are means (95%
confidence intervals) unless stated otherwise
Characteristics Intervention (n=15)* Comparison (n=15)
Age (months) 18.1 (17.6 to 18.7) 18.2 (17.7 to 18.7)
Sex (% female) 47.9 (46.8 to 49.1) 50.9 (49.3 to 52.4)
Birth order 2.7 (2.5 to 2.8) 2.6 (2.5 to 2.7)
Mother’s years of completed schooling 3.6 (3.0 to 4.2) 3.8 (3.2 to 4.4)
Homestead land in decimal 10.4 (9.0 to 11.8) 10.1 (8.5 to 11.7)
Baseline rate of admission to hospital for diarrhoea† 8.1 (6.1 to 10.2) 8.1 (6.1 to 10.3)
*Confidence intervals based on cluster level standard error.
†Per 100 child years observed.
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intervention clusters, but the difference was not statisti›
cally significant (table 5).
A total of 70 children died—33 in the intervention
clusters and 37 in the comparison clusters. Thirty
deaths were due to drowning, and the remaining 40
were not injury related. Because deaths due to injury
(all drowning) were unlikely to be associated with zinc
treatment, we restricted the mortality analysis to
non›injury deaths. The non›injury death rate was 51%
lower in the zinc intervention clusters than in the com›
parison clusters (13 v 27) (table 6).
The lower non›injury death rate in the intervention
clusters was almost entirely due to fewer deaths from
diarrhoea and acute lower respiratory infection.
Diarrhoea and acute lower respiratory infection
together accounted for 10 deaths in the intervention
clusters and 20 deaths in the comparison clusters
(table 7).
We investigated whether there was a pre›existing
difference in child mortality between these two areas or
a difference in children in an age group not included in
the study by using existing data from the Matlab health
and demographic surveillance system. The non›injury
death rates in children aged 3›59 months in zinc inter›
vention and comparison households in the two years
preceding the start of the trial (November 1996 to
October 1998) were 3.8 and 4.0 per 1000 child years—
not significantly different. We also assessed deaths in
children in the first three months of life during the
period of the trial, given that they were not treated with
zinc. There were 62 deaths in children < 3 months of
age in the zinc intervention and 63 in the comparison
areas, resulting in death rates of 151 and 147 per 1000
child years observed, which were not significantly
different.
Discussion
In our study population, children who received zinc
supplementation during and after diarrhoea had 24%
shorter duration of diarrhoea, 15% lower incidence of
diarrhoea, and a trend suggesting fewer diarrhoea
related hospital admissions. The reductions in duration
of both non›dysenteric diarrhoea and dysentery were
significant. The downward trend in the incidence of
acute lower respiratory infection in the zinc treatment
Table 3 Effect of zinc on duration of diarrhoea by type of diarrhoea in a sample of episodes
Type of diarrhoea
Intervention Comparison
Hazards ratio* (95% CI)No of episodes
Mean (SD) episode
duration (days) No of episodes
Mean (SD) episode
duration (days)
Non›dysenteric 560 4.6 (3.6) 582 5.8 (4.7) 0.77 (0.64 to 0.92)
Dysentery 60 6.0 (4.3) 50 7.3 (4.2) 0.62 (0.44 to 0.89)
All 620 4.7 (3.7) 632 5.9 (4.6) 0.76 (0.65 to 0.90)
*Adjusted for child’s age, sex, and birth order, mother’s education, and household homestead land size.
Table 4 Effect of zinc on incidence of diarrhoea and acute lower respiratory infection
Disease Intervention Comparison
Rate ratio
(95% CI)*
Difference in mean
rates (95% CI)†
Diarrhoea:
Periods observed 20 699 21 089
Periods with diarrhoea 3 278 3 947
Unadjusted incidence (%) 15.8 18.7 0.85 (0.76 to 0.96) 2.9 (0.8 to 5.1)
Acute lower respiratory infection:
Periods observed 20 699 21 089
Periods with acute lower
respiratory infection
1 543 1 700
Unadjusted incidence (%) 7.5 8.1 0.93 (0.78 to 1.10) 0.7 (−0.7 to 2.0)
*Based on individual level analysis using random effect Poisson regression model. Adjusted for child’s age,
sex, and birth order, mother’s education, household homestead land size, baseline cluster level diarrhoea
admission rates, and intra›cluster correlation.
†Based on cluster level t test analysis. Differences in mean rates expressed per 100 child years of
observation. Adjusted for child’s age, sex, and birth order, mother’s education, household homestead land
size, and baseline cluster level diarrhoea admission rates.
Table 5 Effect of zinc on diarrhoea related and acute lower respiratory infection related
admission to hospital
Disease Intervention Comparison Rate ratio (95% CI)*
Difference in
mean rates
(95% CI)†
Diarrhoea:
Child years observed 5866 6015
Admissions 478 622
Unadjusted admission rate 8.15 10.34 0.76 (0.59 to 0.98) 2.2 (−0.04 to 4.5)
Acute lower respiratory infection:
Child years observed 5866 6015
Admissions 296 360
Unadjusted admission rate 5.05 5.99 0.81 (0.53 to 1.23) 0.9 (−1.8 to 3.6)
*Based on individual level analysis using random effect Poisson regression model. Adjusted for child’s age,
sex, and birth order, mother’s education, household homestead land size, baseline cluster level diarrhoea
admission rates, and intra›cluster correlation.
†Based on cluster level t test analysis. Differences in mean rates expressed per 100 child years of
observation. Adjusted for child’s age, sex, and birth order, mother’s education, household homestead land
size, and baseline cluster level diarrhoea admission rates.
Table 6 Effect of zinc on non›injury child deaths
Non›injury deaths Intervention Comparison Rate ratio* (95% CI)
Difference of mean
rates (95% CI)†
Child years observed 5866 6015
Non›injury deaths 13 27
Non›injury death rates 2.22 4.49 0.49 (0.25 to 0.94) 2.2 (0.6 to 3.7)
*Based on individual level analysis using random effect Poisson regression model. Adjusted for child’s age,
sex, and birth order, mother’s education, household homestead land size, baseline cluster level diarrhoea
admission rates, and intra›cluster correlation.
†Based on cluster level t test analysis. Differences of mean rates expressed per 1000 child years of
observation. Adjusted for child’s age, sex, and birth order, mother’s education, household homestead land
size, and baseline cluster level diarrhoea admission rates.
Fig 2 Incidence of acute lower respiratory infection by area and
study period
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group, but not in the comparison group, and the 19%
reduction in admissions for acute lower respiratory
infection, although not statistically significant, also sug›
gested a benefit of zinc.
The reduction in the duration of diarrhoeal
episode is consistent with earlier studies.11 12 A
meta›analysis of five studies of zinc treatment for acute
diarrhoea found a summary estimate for reduction in
duration of 16%.3 Possible mechanisms for the effect of
zinc treatment on the duration of diarrhoea include
improved absorption of water and electrolytes by the
intestine,13 faster regeneration of gut epithelium,14
increased levels of enterocyte brush border enzymes,15
and enhanced immune response,16 leading to early
clearance of diarrhoeal pathogens from the intestine.17
Several recent controlled trials have shown a
preventive effect of routine zinc supplementation on
the incidence of diarrhoea4 18 19 and acute lower
respiratory infection.20 21 However, these studies pro›
vided daily zinc supplementation for a period of 6›12
months, which is often not feasible in large scale
programmes. Three studies in which zinc was given for
two weeks during and after diarrhoea found reductions
in episodes of diarrhoea or respiratory disease in sub›
sequent two to three month periods without additional
zinc supplements.4 The lower rates of diarrhoea and
acute lower respiratory infection in this and other
studies indicate that a reduction in incidence could be
due to a systemic effect of zinc, probably through
enhanced immune function.11 12 16 The reduction in
hospital admissions for diarrhoea could have been due
to effects of zinc on episode duration, reduced
incidence, or altered care seeking behaviour. A recent
study from Bangladesh reported a higher prevalence
of acute lower respiratory infection in Bangladeshi
children in a six month follow up period after receipt
of 20 mg elemental zinc daily for 14 days.22 The preva›
lence of acute lower respiratory infection was, however,
lower in children who received a 200 000 IU vitamin A
capsule after 14 days of zinc supplementation. A
national programme in Bangladesh gives a six
monthly vitamin A distribution to children aged 6
months to 6 years. Almost all our study children
received vitamin A capsules every six months, so the
findings of that study may not be inconsistent with
ours. In that study, all children received daily
supplements for 14 days at the beginning of a six
month follow up period.22 In contrast, we supple›
mented children during each episode of diarrhoea, a
targeted approach to zinc supplementation that is
much more feasible to implement.
The most important aspect of our study is that it
shows for the first time a reduction in non›injury
deaths from the use of zinc as a treatment for
diarrhoea. About half the number of non›injury deaths
occurred in the intervention clusters than in the com›
parison clusters. This difference was significant, even in
the rigorous statistical analysis for the cluster level
design, controlling for confounding variables. We
believe, therefore, that the lower mortality can be
attributed to zinc supplementation. The magnitude of
the effect of zinc was greater for mortality than for
morbidity, which may reflect a greater reduction in
severity than incidence of disease. Vitamin A
supplementation is a precedent for this—it had small
effects on diarrhoea morbidity and none on acute
lower respiratory infection morbidity, yet it resulted in
about 23% reduction in mortality in children aged 6
months to 5 years.23 A recently published randomised
trial from India found a large reduction in overall mor›
tality in infants who were small for gestational age and
supplemented daily with zinc from 1 to 9 months of
age.24
The intervention we evaluated is simple and
inexpensive and can be incorporated into existing
diarrhoeal disease control efforts. Further study is
needed to determine whether zinc should be given as a
supplement or can be incorporated into oral rehydra›
tion solution.
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Science commentary: What does zinc do?
Abi Berger
Adequate zinc intake is critical for health. Zinc
deficiency affects cells of the immune system. It causes
a reduction in the number B lymphocytes and T
lymphocytes (CD4 lymphocytes in particular) through
increased apoptosis and also reduces their functional
capacity. The functions of the macrophage, another
key immunological cell that engulfs and destroys
bacteria, are also compromised. The production and
potency of several cytokines, the central messengers of
the immune system, are also perturbed by zinc
deficiency. Many of these changes occur even in the
early stages of deficiency.
Zinc plays a part in the maintenance of epithelial
and tissue integrity through promoting cell growth
and suppressing apoptosis and through its underap›
preciated role as an antioxidant, protecting against free
radical damage during inflammatory responses. Thus,
in the case of diarrhoea, multiple functions of zinc may
help to maintain the integrity of the gut mucosa to
reduce or prevent fluid loss. Notably, these responses
can occur within 48 hours, much more rapidly than the
direct effects of zinc on cellular development.
The recommended daily allowance is only 10 mg
elemental zinc, but many people in both developing
and industrialised countries do not have this in their
diet.1 Zinc deficiency is biochemically defined as a
serum concentration of less than 9 ìmol/l. However,
serum zinc concentrations may not fully reflect the
physiological zinc status in an individual, and individu›
als with apparently normal serum concentrations may
benefit from daily zinc supplements.2
Benefits of supplementation
This is clearly illustrated in several randomised
controlled trials of zinc supplementation. A meta›
analysis indicated that daily zinc supplementation can
reduce the incidence of pneumonia by 41% and
diarrhoea by 18%.3 A meta›analysis of trials of adjunc›
tive zinc supplementation in children with diarrhoea
reduced the duration of the illness by 24%.4 A trial of
daily zinc supplementation in otherwise healthy
children from New Guinea reduced the number of
cases of malaria seen at a health clinic by 38%.5
There is also evidence that zinc supplementation
could offer benefit to pregnant women and their
babies.6 One study showed that prenatal zinc
supplementation can increase birth weight,7 and
another indicated reduced incidence of diarrhoea and
other morbidities in the infants.8 Babies who are small
for gestational age also seem to benefit from taking
daily zinc supplementation. A trial in India found that
babies who received zinc from 1 month onwards were
60% less likely to die during infancy.9 Lastly, several
studies indicate a potential role for zinc and
supplements that contain zinc in improving immune
status10 and health in elderly people.11 Zinc supplemen›
tation, therefore, seems be particularly critical during
periods of immune development or degeneration:
early childhood, pregnancy, and later life.
Problems caused by too much zinc
Taking too much daily zinc could also be a problem
because, although it is not toxic, high doses can impair
Papers
Abi Berger
science editor, BMJ
page 6 of 7 BMJ VOLUME 325 9 NOVEMBER 2002 bmj.com
copper absorption. This can lead to copper deficiency
with immunosuppression and other subtle and appar›
ent adverse effects, especially for the mother and fetus
during pregnancy.12 For this reason, doses more than
twice the recommended daily allowance are not
recommended and prenatal zinc supplements should
contain copper,13 especially in populations with low
mineral intakes.
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